The plexiform neurofibroma microenvironment

Cancer Microenvironment

Volumn 5, Issue 3, 2012, Pages 307-310

  Yang, Feng Chun ^a   Staser, Karl ^a   Clapp, D Wade ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Mast cells; Neurofibromas; NF1; Tumor microenvironment

Indexed keywords

BLOOD VESSEL; BONE MARROW TRANSPLANTATION; CARCINOGENESIS; EFFECTOR CELL; FIBROBLAST; HAPLOINSUFFICIENCY; HEMATOPOIETIC STEM CELL; HUMAN; MAST CELL; NEURILEMOMA; NEUROFIBROMA; NONHUMAN; ONCOGENE C KIT; PRIORITY JOURNAL; REVIEW; STROMAL TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

EID: 84863958123     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-012-0115-x     Document Type: Review

References (46)

1. Wallace MR et al (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249(4965):181–186
2. Morris M, Fox WS (1908) Von Recklinghausen’s Disease. Proc R Soc Med 1(Dermatol Sect):16–17
3. Martin GA et al (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63(4):843–849
4. Ballester R et al (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63(4):851–859
5. Hiatt KK et al (2001) Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1−/− cells. J Biol Chem 276(10):7240–7245
6. Bader JL (1986) Neurofibromatosis and cancer. Ann N Y Acad Sci 486:57–65
7. Friedman J et al (1999) Neurofibromatosis: phenotype, natural history, and pathogenesis, 3rd edn. The Johns Hopkins University Press, Baltimore
8. Korf BR (1999) Plexiform neurofibromas. Am J Med Genet 89 (1):31–37
9. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867
10. Coussens LM, Werb Z (2001) Inflammatory cells and cancer: think different! J Exp Med 193(6):F23–F26
11. Kacinski BM (1995) CSF-1 and its receptor in ovarian, endome-trial and breast cancer. Ann Med 27(1):79–85
12. Bergers G et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2(10):737–744
13. Coussens LM et al (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13:1382–1397
14. Franco CB et al (2010) Distinguishing mast cell and granulocyte differentiation at the single-cell level. Cell Stem Cell 6(4):361–368
15. Galli SJ, Maurer M, Lantz CS (1999) Mast cells as sentinels of innate immunity. Curr Opin Immunol 11(1):53–59
16. Theoharides TC, Conti P (2004) Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 25(5):235–241
17. Metz M et al (2006) Mast cells can enhance resistance to snake and honeybee venoms. Science 313(5786):526–530
18. Zhu Y et al (2002) Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296(5569):920–922
19. Viskochil DH (2003) It takes two to tango: mast cell and Schwann cell interactions in neurofibromas. J Clin Invest 112(12):1791–1793
20. Yang FC et al (2003) Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/− mast cells. J Clin Invest 112(12):1851–1861
21. Hirota S et al (1993) Possible involvement of c-kit Receptor and its ligand in increase of mast cells in neurofibroma tissues. Arch Pathol Lab Med 117:996–999
22. Staser K, Yang FC, Clapp DW (2010) Mast cells and the neurofibroma microenvironment. Blood 116(2):157–164
23. Staser K, Yang FC, Clapp DW (2012) Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression. Annu Rev Pathol 7:469–495
24. Staser K, Yang FC, Clapp DW (2010) Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells. Curr Opin Hematol 17(4):287–293
25. Yang FC et al (2008) Nf1-dependent tumors require a microenvironment containing Nf1+/−− and c-kit-dependent bone marrow. Cell 135(3):437–448
26. Greggio H (1911) Les cellules granuleuses (Mastzellen) dans les tissus normaux et dans certaines maladies chirurgicales. Arch Med Exp 23:323–375
27. Pineda A (1965) Mast cells–their presence and ultrastructural characteristics in peripheral nerve tumors. Arch Neurol 13(4):372–382
28. Gamble HJ, Goldby S (1961) Mast cells in peripheral nerve trunks. Nature 189:766–767
29. Olsson Y (1971) Mast cells in human peripheral nerve. Acta Neurol Scand 47(3):357–368
30. Isaacson P (1976) Mast cells in benign nerve sheath tumours. J Pathol 119(4):193–196
31. Baroni C (1964) On the relationship of mast cells to various soft tissue tumours. Br J Cancer 18:686–691
32. Nurnberger M, Moll I (1994) Semiquantitative aspects of mast cells in normal skin and in neurofibromas of neurofibromatosis types 1 and 5. Dermatology 188(4):296–299
33. Riccardi VM (1981) Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells. Birth Defects Orig Artic Ser 17(2):129–145
34. Riccardi VM (1987) Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen. Arch Dermatol 123(8):1011–1016
35. Riccardi VM (1993) A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching. Arch Dermatol 129(5):577–581
36. Galli SJ, Tsai M, Wershil BK (1993) The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 142(4):965–974
37. Chen S et al (2010) Nf1−/− Schwann cell-conditioned medium modulates mast cell degranulation by c-Kit-mediated hyperactivation of phosphatidylinositol 3-kinase. Am J Pathol 177(6):3125–3132
38. Yang FC et al (2006) Nf1+/− mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. Hum Mol Genet 15(16):2421–2437
39. Li F et al (2006) Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells. Hum Mol Genet 15(11):1921–1930
40. Munchhof AM et al (2006) Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. Hum Mol Genet 15 (11):1858–1869
41. McDaniel AS et al (2008) Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/− mast cells. Blood 112(12):4646–4654
42. Ingram DA et al (2000) Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 191(1):181–188
43. Khalaf WF et al (2007) K-ras is critical for modulating multiple c-kit-mediated cellular functions in wild-type and Nf1+/− mast cells. J Immunol 178(4):2527–2534
44. Jaakkola S et al (1989) Type 1 neurofibromatosis: selective expression of extracellular matrix genes by Schwann cells, perineu-rial cells, and fibroblasts in mixed cultures. J Clin Invest 84 (1):253–261
45. Druker BJ (2008) Translation of the Philadelphia chromosome into therapy for CML. Blood 112(13):4808–4817
46. Wu J et al (2008) Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells. Cancer Cell 13(2):105–116